Focused Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,000
| Closed | -$2.16K | – | 1072 |
|
|
2023
Q1 | $2.16K | Hold |
6,000
| – | – | ﹤0.01% | 759 |
|
|
2022
Q4 | $5.32K | Sell |
6,000
-8,000
| -57% | -$7.09K | ﹤0.01% | 603 |
|
|
2022
Q3 | $22K | Hold |
14,000
| – | – | ﹤0.01% | 381 |
|
|
2022
Q2 | $28K | Hold |
14,000
| – | – | 0.01% | 344 |
|
|
2022
Q1 | $33K | Buy |
14,000
+8,000
| +133% | +$18.9K | 0.01% | 352 |
|
|
2021
Q4 | $28K | Sell |
6,000
-5,500
| -48% | -$25.7K | ﹤0.01% | 433 |
|
|
2021
Q3 | $88K | Buy |
11,500
+1,500
| +15% | +$11.5K | 0.01% | 305 |
|
|
2021
Q2 | $97K | Sell |
10,000
-1,230
| -11% | -$11.9K | 0.02% | 295 |
|
|
2021
Q1 | $93K | Sell |
11,230
-1,000
| -8% | -$8.28K | 0.02% | 288 |
|
|
2020
Q4 | $83K | Buy |
12,230
+230
| +2% | +$1.56K | 0.02% | 293 |
|
|
2020
Q3 | $134K | Hold |
12,000
| – | – | 0.03% | 190 |
|
|
2020
Q2 | $75K | Buy |
12,000
+4,000
| +50% | +$25K | 0.02% | 260 |
|
|
2020
Q1 | $15K | Buy |
8,000
+6,500
| +433% | +$12.2K | ﹤0.01% | 406 |
|
|
2019
Q4 | $5K | Buy |
+1,500
| New | +$5K | ﹤0.01% | 565 |
|